• Publications
  • Influence
Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes.
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for attention deficit/hyperactivity disorder (ADHD) specify two dimensions of inattention andExpand
  • 584
  • 57
  • PDF
The Ecological Validity of Delay Aversion and Response Inhibition as Measures of Impulsivity in AD/HD: A Supplement to the NIMH Multimodal Treatment Study of AD/HD
Impulsivity is a primary symptom of the combined type of Attention Deficit/Hyperactivity Disorder (AD/HD). The Stop Signal Paradigm is premised upon a primary deficit in inhibitory control in AD/HD,Expand
  • 596
  • 50
  • PDF
Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration
  • M. Solanto
  • Psychology, Medicine
  • Behavioural Brain Research
  • 1 July 1998
The psychostimulants, D-amphetamine (D-AMP) and methylphenidate (MPH), are widely used to treat attention-deficit hyperactivity disorder (ADHD) in both children and adults. The purpose of this paperExpand
  • 652
  • 34
Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
CONTEXT Attention-deficit/hyperactivity disorder (ADHD) is the most prevalent psychiatric disorder of childhood. There is considerable evidence that brain dopamine is involved in ADHD, but it isExpand
  • 298
  • 25
  • PDF
Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research
  • M. Solanto
  • Psychology, Medicine
  • Behavioural Brain Research
  • 10 March 2002
There is strong evidence that the catecholamines dopamine and norepinephrine are both important in the pathophysiology of ADHD, as well as in the mechanism of therapeutic action of stimulant drugs.Expand
  • 432
  • 21
  • PDF
Efficacy of meta-cognitive therapy for adult ADHD.
OBJECTIVE The authors investigated the efficacy of a 12-week manualized meta-cognitive therapy group intervention designed to enhance time management, organization, and planning in adults withExpand
  • 283
  • 19
Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes
The Predominantly Inattentive (PI) and Combined (CB) subtypes of AD/HD differ in cognitive tempo, age of onset, gender ratio, and comorbidity, yet a differentiating endophenotype has not beenExpand
  • 138
  • 14
Clinical psychopharmacology of AD/HD: Implications for animal models
  • M. Solanto
  • Psychology, Medicine
  • Neuroscience & Biobehavioral Reviews
  • 31 January 2000
A working knowledge of the clinical psychopharmacology of the psychostimulants in AD/HD is essential to the development of valid animal models of the disorder. The clinical pharmacokinetics andExpand
  • 87
  • 12
Brain dopamine transporter levels in treatment and drug naïve adults with ADHD
We investigate dopamine transporters in ADHD subjects with control of potentially confounding factors (previous medication and/or drug histories, comorbidity) and their association with clinical symptoms. Expand
  • 219
  • 11
Child and Parent Response to the 1993 World Trade Center Bombing
This study evaluated children's symptoms 3 and 9 months after the 1993 bombing of the World Trade Center, and the relationship between parent and child reactions when only the children had been inExpand
  • 141
  • 10
  • PDF